{"slideshow_credits": null, "snippet": "In a trial, the pill, called Quad, had roughly the same rate of side effects as two existing therapies, but patients did slightly better when their blood was tested for the virus.", "abstract": "Studies published in The Lancet show that Quad, a new once-a-day pill combining four AIDS drugs, has proved slightly more effective than two existing once-a-day regimens; pill is made by Gilead Sciences and is expected to be approved by the Food and Drug Administration later in 2012.", "section_name": "Health", "print_page": "6", "document_type": "article", "byline": {"person": [{"lastname": "McNEIL", "qualifier": "Jr", "rank": 1, "firstname": "Donald", "role": "reported", "organization": "", "middlename": "G."}], "original": "By DONALD G. McNEIL Jr", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/07/03/health/quad-once-a-day-pill-tests-better-than-other-regimens.html", "lead_paragraph": "In a trial, the pill, called Quad, had roughly the same rate of side effects as two existing therapies, but patients did slightly better when their blood was tested for the virus.", "headline": {"seo": "Quad Once-a-Day Pill Tests Better Than Other Regimens", "main": "AIDS: New Four-Drug Pill Taken Daily Tests Better Than Other Regimens", "print_headline": "Aids: New Four-Drug Pill Taken Daily Tests Better Than Other Regimens", "content_kicker": "Global Update"}, "_id": "53f86f9138f0d835538dcb13", "word_count": "230", "multimedia": [{"height": 338, "url": "images/2012/07/03/science/03GLOB_SPAN/GLOBAL-articleLarge.jpg", "legacy": {"xlarge": "images/2012/07/03/science/03GLOB_SPAN/GLOBAL-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "338"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2012/07/03/science/03GLOB_SPAN/GLOBAL-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/07/03/science/03GLOB_SPAN/GLOBAL-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-07-03T00:00:00Z", "source": "The New York Times", "news_desk": "Science", "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Medicine and Health", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Gilead Sciences Inc", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Lancet, The (Journal)", "name": "organizations", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}